Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)Franklin, M.C., Kadkhodayan, S., Ackerly, H., Alexandru, D., Distefano, M.D., Elliott, L.O., Flygare, J.A., Mausisa, G., Okawa, D.C., Ong, D., Vucic, D., Deshayes, K., Fairbrother, W.J.
(2003) Biochemistry 42: 8223-8231
- PubMed: 12846571
- DOI: 10.1021/bi034227t
- Primary Citation of Related Structures:  1OXQ, 1OY7
- Also Cited By: 1TW6, 2I3H, 2I3I
- PubMed Abstract:
- SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)
Vucic, D.,Deshayes, K.,Ackerly, H.,Pisabarro, M.T.,Kadkhodayan, S.,Fairbrother, W.J.,Dixit, V.M.
(2002) J.Biol.Chem. 277: 12275
- ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D.,Stennicke, H.R.,Pisabarro, M.T.,Salvesen, G.S.,Dixit, V.M.
(2000) Curr.Biol. 10: 1359
Melanoma inhibitor of apoptosis (ML-IAP) is a potent anti-apoptotic protein that is upregulated in a number of melanoma cell lines but not expressed in most normal adult tissues. Overexpression of IAP proteins, such as ML-IAP or the ubiquitously expr ...
Melanoma inhibitor of apoptosis (ML-IAP) is a potent anti-apoptotic protein that is upregulated in a number of melanoma cell lines but not expressed in most normal adult tissues. Overexpression of IAP proteins, such as ML-IAP or the ubiquitously expressed X-chromosome-linked IAP (XIAP), in human cancers has been shown to suppress apoptosis induced by a variety of stimuli. Peptides based on the processed N-terminus of Smac/DIABLO can negate the ability of overexpressed ML-IAP or XIAP to suppress drug-induced apoptosis. Such peptides have been demonstrated to bind to the single baculovirus IAP repeat (BIR) of ML-IAP and the third BIR of XIAP with similar high affinities (approximately 0.5 microM). Herein, we use phage-display of naïve peptide libraries and synthetic peptides to investigate the peptide-binding properties of ML-IAP-BIR and XIAP-BIR3. X-ray crystal structures of ML-IAP-BIR in complex with Smac- and phage-derived peptides, together with peptide structure-activity-relationship data, indicate that the peptides can be modified to provide increased binding affinity and selectivity for ML-IAP-BIR relative to XIAP-BIR3. For instance, substitution of Pro3' in the Smac-based peptide (AVPIAQKSE) with (2S,3S)-3-methylpyrrolidine-2-carboxylic acid [(3S)-methyl-proline] results in a peptide with 7-fold greater affinity for ML-IAP-BIR and about 100-fold specificity for ML-IAP-BIR relative to XIAP-BIR3.
Department of Protein Engineering, Genentech, Inc., One DNA Way, South San Francisco, California 94080, USA.